This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing BTK inhibitors in autoimmune indications
Ticker(s): NVS, BMY, GILD, SNYWho's the expert?
Institution: Mayo
- Neurologist and scientist who leads a research team studying autoimmune neurological diseases.
- Clinical research interests include characterizing the effects of immunotherapies to achieve the best outcomes, better understanding how autoimmune encephalitis affects people to define markers and measure effectiveness in clinical trials.
- Laboratory interests include researching the cross-compartmental dynamics of B cells. The team studies B cell receptor sequence profiles in spinal fluid and blood, and the neck lymph nodes.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
